38 related articles for article (PubMed ID: 11221090)
1. Rifampicin Allergy Leading to Acute Renal Shutdown.
Jeyasekharan R; George N
Int J Appl Basic Med Res; 2023; 13(1):47-49. PubMed ID: 37266527
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
[TBL] [Abstract][Full Text] [Related]
3. Fixed drug eruption and anaphylaxis induced concurrently by erdosteine: a case report.
Sim DW; Yu JE; Koh YI
Allergy Asthma Clin Immunol; 2021 Feb; 17(1):15. PubMed ID: 33546741
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin induced shock during re-exposure for treatment of latent tuberculosis.
Harlow CF; Meghji J; Martin L; Harris T; Kon OM
BMJ Case Rep; 2020 Feb; 13(1):. PubMed ID: 32014989
[TBL] [Abstract][Full Text] [Related]
5. Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review.
Chen G; He JQ
Medicine (Baltimore); 2017 Feb; 96(7):e6135. PubMed ID: 28207542
[TBL] [Abstract][Full Text] [Related]
6. A case of serum sickness-like reaction and anaphylaxis - induced simultaneously by rifampin.
Kim DH; Choi YH; Kim HS; Yu JE; Koh YI
Allergy Asthma Immunol Res; 2014 Mar; 6(2):183-5. PubMed ID: 24587958
[TBL] [Abstract][Full Text] [Related]
7. Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin.
Havey TC; Cserti-Gazdewich C; Sholzberg M; Keystone JS; Gold WL
Am J Trop Med Hyg; 2012 Feb; 86(2):264-7. PubMed ID: 22302861
[TBL] [Abstract][Full Text] [Related]
8. Serious side effects of rifampin on the course of WHO/MDT: a case report.
Namisato M; Ogawa H
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):277-82. PubMed ID: 11221090
[TBL] [Abstract][Full Text] [Related]
9. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
10. [Immuno-allergic accidents with rifamipcin].
Flageul B; Wagner L; Cottenot F
Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
[TBL] [Abstract][Full Text] [Related]
11. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
13. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
